FitLife Brands (FTLF) AI Stock Analysis

• Market Cap: $134.39M
• Dividend Yield: N/A
• Average Volume (3M): 16.72K
• Price to Earnings (P/E): 15.8
• Beta (1Y): 0.57
• Revenue Growth: 9.14%
• EPS Growth: 18.87%
• Country: US
• Employees: 39
• Sector: Consumer Defensive
• Sector Strength: 63
• Industry: Packaged Foods
• EPS (TTM): 0.20
• Shares Outstanding: 9,391,072
• 10 Day Avg. Volume: 9,194
• 30 Day Avg. Volume: 16,717
• PEG Ratio: -1.07
• Price to Book (P/B): 3.39
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 19.54
• Enterprise Value/Market Cap: 0.99
• Enterprise Value/Revenue: 0.53
• Enterprise Value/Gross Profit: 4.82
• Enterprise Value/Ebitda: 2.62
• 1Y Price Target: $20.50
• Price Target Upside: 43.26% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 75 Outperform
• Price Target: $16.00 ▲(11.81%Upside)

FitLife Brands' overall score reflects strong financial performance and strategic positioning, balanced by mixed technical signals and recent revenue challenges. The company's past growth and strategic investments are positive, but vigilance on maintaining profitability is crucial.

Positive Factors

Earnings Performance

Earnings growth significantly outpaced revenue growth, with EPS rising 40% to $0.21.

Market Position

FitLife's unique position executing a roll-up strategy in the fragmented supplement industry offers a compelling opportunity for investors.

Revenue Growth

Revenue grew 13% year-over-year to $15.0M, driven by strong online sales and contributions from recently acquired brands.

Negative Factors

Share Price

Despite significant share price growth, further multiple expansion can be supported by growth in existing brands and expanding the portfolio with new brands.

FitLife Brands Business Overview & Revenue Model

Company Description

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. It offers weight loss, general health, and sports nutrition supplements; precision sports nutrition formulations for professional muscular development; weight loss and sports nutrition performance enhancing supplements for fitness enthusiasts; and men's health and weight loss formulations, as well as other diet, health, and sports nutrition supplements and related products; and sports nutritional products, energy and weight loss products, and meal replacements. It markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Metis Nutrition, iSatori, BioGenetic Laboratories, and Energize through franchised stores, as well as through various retail locations, including specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.

How the Company Makes Money

FitLife Brands generates revenue through the sale of its nutritional supplements and wellness products. The company's primary revenue streams include direct sales to consumers through online platforms and wholesale distribution to various retail partners, including specialty health stores and fitness centers. FitLife Brands also engages in strategic partnerships and collaborations with key industry players to expand its market reach and enhance its product offerings. Additionally, the company invests in marketing and brand-building initiatives to drive consumer engagement and increase sales.

FitLife Brands Financial Statement Overview

Summary

FitLife Brands demonstrates strong financial performance with solid revenue growth, robust profitability, conservative leverage, and strong cash flow generation. The company maintains effective cost management and operational efficiency, though vigilance on maintaining margins is recommended.

Income Statement

FitLife Brands has demonstrated strong revenue growth with a consistent upward trajectory, notably a 22.35% increase from 2023 to 2024. The company's gross profit margin is robust at 43.55%, complemented by a healthy net profit margin of 13.93%. EBIT and EBITDA margins are also strong at 20.36% and 20.71% respectively, indicating effective cost management and operational efficiency. Overall, the income statement reflects solid profitability, though continued vigilance on maintaining margins is recommended.

Balance Sheet

FitLife Brands exhibits a solid balance sheet with a low debt-to-equity ratio of 0.14, indicating conservative leverage. The equity ratio stands at 61.72%, showcasing a strong equity base relative to total assets. Return on equity is impressive at 24.86%, highlighting effective utilization of equity to generate profits. While the balance sheet is stable, attention to maintaining low leverage and high equity levels will be crucial.

Cash Flow

The company shows significant growth in free cash flow, with a 133.35% increase from 2023 to 2024. Operating cash flow to net income ratio is 1.07, indicating good cash generation relative to net income. The free cash flow to net income ratio is 1.07, demonstrating strong cash flow conversion. The cash flow statement reflects healthy cash management and operational strength, supporting future growth and investment.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
63.86M	64.47M	52.70M	28.80M	27.90M	21.74M
	Gross Profit
27.67M	28.08M	21.43M	12.03M	12.49M	9.39M
	EBIT
12.70M	13.12M	7.55M	5.70M	6.22M	4.20M
	EBITDA
12.91M	13.35M	8.12M	5.89M	6.81M	4.38M
	Net Income Common Stockholders
8.84M	8.98M	5.30M	4.43M	5.41M	8.82M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
6.63M	4.47M	1.14M	13.28M	9.90M	6.34M
	Total Assets
18.35M	58.53M	55.35M	25.71M	21.48M	16.77M
	Total Debt
196.00K	13.46M	20.15M	103.00K	158.00K	661.00K
	Net Debt
-6.43M	8.99M	19.01M	-13.17M	-9.74M	-5.67M
	Total Liabilities
4.50M	22.41M	28.31M	4.32M	4.19M	4.74M
	Stockholders Equity
13.85M	36.13M	27.04M	21.39M	17.29M	12.03M
Cash Flow		Free Cash Flow
6.88M	9.60M	4.11M	4.13M	4.48M	5.72M
	Operating Cash Flow
6.90M	9.61M	4.22M	4.13M	4.48M	5.72M
	Investing Cash Flow
-24.00K	-10.00K	-35.99M	0.00	-529.00K	0.00
	Financing Cash Flow
-4.22M	-6.98M	20.30M	-750.00K	-390.00K	350.00K

FitLife Brands Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 14.31
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FTLF, the sentiment is Negative. The current price of 14.31 is below the 20-day moving average (MA) of 14.55, above the 50-day MA of 13.77, and below the 200-day MA of 15.29, indicating a neutral trend. The MACD of 0.05 indicates Positive momentum. The RSI at 48.51 is Neutral, neither overbought nor oversold. The STOCH value of 32.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FTLF.

FitLife Brands Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NATR	77 Outperform	$266.27M	27.11	6.42%	―	2.00%	-37.09%
FTLF	75 Outperform	$134.39M	15.77	25.89%	―	9.14%	18.87%
LFVN	70 Outperform	$157.60M	17.93	30.11%	1.32%	8.22%	159.71%
Sector *	65 Neutral	$8.89B	15.01	4.75%	203.76%	3.54%	-2.49%
LSF	53 Neutral	$70.92M	―	-7.38%	―	25.04%	87.51%
PAVS	43 Neutral	$60.60M	―	-71.88%	―	-93.33%	―
BRLS	31 Underperform	$110.76M	―	-370.71%	―	―	-163.87%

FitLife Brands Corporate Events

FitLife Brands Reports Q1 2025 Revenue Decline

FitLife Brands announced its financial results for the first quarter of 2025, reporting a 4% decrease in total revenue to $15.9 million compared to the same period in 2024. Online sales accounted for 67% of total revenue but decreased by 2%, while the company’s net income fell to $2.0 million from $2.2 million. Despite these declines, Legacy FitLife saw a 5% revenue increase, driven by an 11% rise in online sales and a 2% increase in wholesale revenue, with gross profit and contribution both increasing by 11%.

The most recent analyst rating on (FTLF) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on FitLife Brands stock, see the FTLF Stock Forecast page.

FitLife Brands Appoints Shannon Pappas to Board

On April 25, 2025, FitLife Brands appointed Shannon Pappas as an independent member of its Board of Directors, following the resignation of Todd Ordal. Pappas brings over 25 years of experience in beauty, skincare, health, fitness, and consumer goods, with expertise in strategic growth and digital commerce. Her appointment is part of FitLife’s commitment to refreshing board composition in line with good corporate governance practices. The transition is expected to enhance FitLife’s strategic direction and capitalize on evolving consumer trends, as the company continues to focus on innovation and growth.

FitLife Brands Unveils New Corporate Presentation

On April 22, 2025, FitLife Brands, Inc. introduced a new corporate presentation for business purposes. This move is part of the company’s ongoing efforts to enhance its corporate communications and potentially improve its market positioning.

FitLife Brands Reports Strong 2024 Financial Performance

FitLife Brands reported a strong financial performance for the fourth quarter and full year of 2024, with total revenue for the year increasing by 22% to $64.5 million and net income rising by 70% to $9.0 million. The company’s online sales, which accounted for 67% of total revenue, grew by 29% over the year, while acquisitions of Mimi’s Rock Corp and MusclePharm assets contributed significantly to wholesale revenue. The improved financial results reflect FitLife’s strategic focus on expanding its market presence and enhancing profitability, positioning the company favorably within the nutritional supplements industry.

FitLife Brands Projects Strong Financial Growth for 2024

On March 13, 2025, FitLife Brands announced its participation in the 37th Annual Roth Conference scheduled for March 17-18, 2025, and provided a financial and operational update. The company anticipates a significant increase in its financial performance for the full year 2024, with net revenue expected to rise by 21-23%, adjusted EBITDA by 38-40%, and net income by 68-72% compared to 2023. As of December 31, 2024, FitLife had $13.1 million outstanding on its term loan and $4.5 million in cash, with no balance on its revolver.